# Efficacy of Gefitinib, an Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase, in Symptomatic Patients With Non–Small Cell Lung Cancer

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/efficacy-of-gefitinib-an-inhibitor-of-the-epidermal-growth-factor-receptor/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Mark G. Kris,Ronald B. Natale,Roy S. Herbst,T. J. Lynch,Diane Prager,Chandra P. Belani,Joan H. Schiller,Karen Kelly,H. Spiridonidis,Alan Sandler,Kathy S. Albain,David Cella,Michael Wolf,Steven D. Averbuch,Judith Ochs,Andrea Kay |
| Citations | 2,541 |
| DOI | 10.1001/jama.290.16.2149 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2120718661 |
| PMID | 14570950 |
| Type | article |
| Year | 2003 |

## Paper authors

- [Mark G. Kris](https://scholariq.org/researchers/mark-g-kris/)
- [David Cella](https://scholariq.org/researchers/david-cella/)

## Paper journal

- [JAMA](https://scholariq.org/journals/jama/)

## Paper primary topic

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Paper topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.